Ftse Mib
34.156,04
-0,64%
DAX
18.504,73
-0,51%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
62.872,47
-3,05%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX BioPharmX Corporation (BPMX) BioPharmX Corporation (BPMX) Notizie

BPMX

BioPharmX (BPMX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX
DataOraFonteTitoloSimboloCompagnia
13/12/201622:05PR Newswire (US)BioPharmX Corporation Reports Third Quarter Financial ResultsAMEX:BPMXBioPharmX Corporation
12/12/201623:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
07/12/201615:00PR Newswire (US)BioPharmX to present evidence that BPX-01 topical minocycline gel may reduce acne-associated inflammationAMEX:BPMXBioPharmX Corporation
06/12/201614:00PR Newswire (US)BioPharmX to Report Third Quarter Financial ResultsAMEX:BPMXBioPharmX Corporation
05/12/201615:00PR Newswire (US)BioPharmX Presents Research at Cell Biology 2016 Showing How Molecular Iodine Promotes Breast Health by Attacking Fibrocystic...AMEX:BPMXBioPharmX Corporation
02/12/201620:38Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BPMXBioPharmX Corporation
02/12/201620:37Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BPMXBioPharmX Corporation
01/12/201623:00Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BPMXBioPharmX Corporation
29/11/201619:15Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
28/11/201622:15PR Newswire (US)BioPharmX Corporation Announces Closing of a $12.5 Million Unit OfferingAMEX:BPMXBioPharmX Corporation
23/11/201612:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(1) (424b1)AMEX:BPMXBioPharmX Corporation
22/11/201614:45PR Newswire (US)BioPharmX Corporation Announces Pricing of Unit OfferingAMEX:BPMXBioPharmX Corporation
22/11/201614:00Edgar (US Regulatory)Registration of Additional Securities (up to 20%) (s-1mef)AMEX:BPMXBioPharmX Corporation
22/11/201612:01Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BPMXBioPharmX Corporation
18/11/201622:58Edgar (US Regulatory)Securities Registration Statement (s-1/a)AMEX:BPMXBioPharmX Corporation
10/11/201615:00PR Newswire (US)BioPharmX Presents BPX-01 Topical Minocycline Gel Acne Data at SDEF's 17th Annual Las Vegas Dermatology SeminarAMEX:BPMXBioPharmX Corporation
26/10/201615:15PR Newswire (US)BioPharmX Studies Suggest its Violet® Iodine Formulation Inhibits Growth of Both FBC and Common Breast Cancer Cells in vitroAMEX:BPMXBioPharmX Corporation
14/10/201622:12Edgar (US Regulatory)Securities Registration Statement (s-1)AMEX:BPMXBioPharmX Corporation
07/10/201623:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:BPMXBioPharmX Corporation
27/09/201622:53Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:BPMXBioPharmX Corporation
26/09/201622:06Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)AMEX:BPMXBioPharmX Corporation
26/09/201615:00PR Newswire (US)BioPharmX Announces Registered Direct OfferingAMEX:BPMXBioPharmX Corporation
14/09/201623:02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:BPMXBioPharmX Corporation
14/09/201622:18Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:BPMXBioPharmX Corporation
14/09/201622:15Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BPMXBioPharmX Corporation
12/09/201622:05PR Newswire (US)BioPharmX Corporation Reports Second Quarter Financial ResultsAMEX:BPMXBioPharmX Corporation
02/09/201614:00PR Newswire (US)BioPharmX to Report Second Quarter Financial Results on September 12, 2016AMEX:BPMXBioPharmX Corporation
24/08/201614:00PR Newswire (US)BioPharmX Enrolls First Subject in OPAL Phase 2b Clinical Trial of BPX-01 Topical Minocycline for the Treatment of AcneAMEX:BPMXBioPharmX Corporation
22/08/201614:00PR Newswire (US)BioPharmX Announces Final Phase 2a Trial Results Find BPX-01 Reduces Facial P. Acnes by More than 90% in Four WeeksAMEX:BPMXBioPharmX Corporation
21/07/201614:00PR Newswire (US)BioPharmX Study Shows BPX-01 Topical Gel Delivers Minocycline Precisely to the SkinAMEX:BPMXBioPharmX Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX

La tua Cronologia

NASDAQ
MRIN
Marin Software
AMEX
HEB
Hemispherx Biopharma
NASDAQ
RNWWW
ReNew Energy Global
TSX
FQC
CI MSCI Canada Quality I...
NASDAQ
TNCC
COIN
UETETH
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network